KLAS Contact
Contact KLAS
Contact KLAS
2023 BEST IN KLAS
Preferences
Related Series
2021
2020
2016
2013
2011
2010
Related Segments
CDS Point-of-Care Reference 2022
How Are Solutions Being Adopted by Clinical Users?
Author
Joe VanDeGraaff
Author
Jennifer Hickenlooper
Current Time Inside Cache Tag Helper: 12/3/2023 12:29:07 AM and Model.reportId = 2058
CDS reference tools enable clinical users to follow standard treatment recommendations and more quickly and confidently make clinical decisions. However, tools that lack strong content, searchability, and EMR integration are not efficient for point-of-care workflows and can frustrate users, especially those already experiencing burnout. Some CDS vendors are addressing user frustration and report their solutions have evolved to be more user friendly. To understand the customer experience and how each solution is being adopted, this report draws on feedback from a subset of clinical users (defined in this report as physicians, nurses, and pharmacists) as well as feedback from vendors’ general customer bases.if you don't have a login, getting started is easy.
Key Findings:
- Wolters Kluwer: UpToDate Improves Patient Care & Workflow Efficiencies for Clinical Users at Point of Care
- EBSCO Information Services: Physician Buy-In Slow; Adopters Report Positive Point-of- Care Experiences
- Merative (IBM): Pharmacists Value Drug Content; User Interface Seen as Outdated
- Elsevier: Users Appreciate Deep Content for Complex Conditions; Point-of-Care Use Not Yet Validated
Writer
Natalie Hopkins
Designer
Breanne Hunter
Project Manager
John Wilson
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2023 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.